S
Shinya Goto
Researcher at Tokai University
Publications - 342
Citations - 30572
Shinya Goto is an academic researcher from Tokai University. The author has contributed to research in topics: Stroke & Atrial fibrillation. The author has an hindex of 67, co-authored 308 publications receiving 26556 citations. Previous affiliations of Shinya Goto include Scripps Research Institute & University of Birmingham.
Papers
More filters
Journal ArticleDOI
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger,John H. Alexander,Renato D. Lopes,Elaine M. Hylek,Michael G. Hanna,Hussein R. Al-Khalidi,Jack Ansell,Dan Atar,Alvaro Avezum,M. Cecilia Bahit,Rafael Diaz,J. Donald Easton,Justin A. Ezekowitz,Greg C. Flaker,David A. Garcia,Margarida Geraldes,Bernard J. Gersh,Sergey P. Golitsyn,Shinya Goto,Antonio G. Hermosillo,Stefan H. Hohnloser,John D. Horowitz,Puneet Mohan,Petr Jansky,Basil S. Lewis,Jose Lopez-Sendon,Prem Pais,Alexander Parkhomenko,Jun Zhu,Lars Wallentin +29 more
TL;DR: In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
Journal ArticleDOI
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega,Eugene Braunwald,Stephen D. Wiviott,Jean-Pierre Bassand,Deepak L. Bhatt,Christoph Bode,Paul Burton,Marc Cohen,Nancy Cook-Bruns,Shinya Goto,Sabina A. Murphy,Alexei N. Plotnikov,David J. Schneider,Xiang Sun,C. Michael Gibson +14 more
TL;DR: In patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke in a double-blind, placebo-controlled trial.
Journal ArticleDOI
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca,Deepak L. Bhatt,Marc Cohen,Philippe Gabriel Steg,Robert F. Storey,Eva C. Jensen,Giulia Magnani,Sameer Bansilal,M. Polly Fish,KyungAh Im,Olof Bengtsson,Ton Oude Ophuis,Andrzej Budaj,Pierre Theroux,Mikhail Ruda,Christian W. Hamm,Shinya Goto,Jindrich Spinar,Jose C. Nicolau,Róbert Gábor Kiss,Sabina A. Murphy,Stephen D. Wiviott,Peter Held,Eugene Braunwald,Marc S. Sabatine +24 more
TL;DR: In patients with a myocardial infarction more than 1 year previously, treatment with ticagrelor significantly reduced the risk of cardiovascular death, my Cardiac Infarction, or stroke and increased therisk of major bleeding.
Journal ArticleDOI
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis
Deepak L. Bhatt,P. Gabriel Steg,E. Magnus Ohman,Alan T. Hirsch,Yasuo Ikeda,Jean-Louis Mas,Shinya Goto,Chiau Suong Liau,Alain J. Richard,Joachim Röther,Peter W.F. Wilson +10 more
TL;DR: This large, international, contemporary database shows that classic cardiovascular risk factors are consistent and common but are largely undertreated and undercontrolled in many regions of the world.
Journal ArticleDOI
One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis
Ph. Gabriel Steg,Deepak L. Bhatt,Peter W.F. Wilson,Ralph B. D'Agostino,E. Magnus Ohman,Joachim Röther,Chiau-Suong Liau,Alan T. Hirsch,Jean-Louis Mas,Yasuo Ikeda,Michael J. Pencina,Shinya Goto +11 more
TL;DR: The reduction of atherosclerotic arterial disease (REACH) registry as discussed by the authors is an international, prospective cohort of 68,236 patients with either established coronary artery disease (CAD, PAD, CVD), or at least three risk factors for atherothrombosis (n = 12,422).